Muscle relaxation monitoring device, muscle relaxation monitoring program, and recording medium
The muscle relaxation monitoring device quickly identifies and addresses installation abnormalities in electromyography-based systems, enhancing surgical readiness by providing real-time feedback on electrode placement and functionality.
Patent Information
- Application Number
- JP2023084124
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-22
- Publication Date
- 2024-12-04
- Estimated Expiration
- 2043-05-22
AI Technical Summary
Electromyography-based muscle relaxation monitoring devices face installation abnormalities such as electrode peeling or improper attachment, which can delay surgical preparations due to the need to identify and rectify these issues.
A muscle relaxation monitoring device with a stimulation output section, signal detection unit, and cause determination unit that identifies the cause of installation abnormalities by analyzing electrical signals from the body, providing real-time feedback on electrode placement and functionality.
Enables rapid identification and correction of installation issues, thereby speeding up surgical preparations and ensuring accurate muscle relaxation monitoring.
Smart Images

Figure 2024167794000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a muscle relaxation monitoring device, a muscle relaxation monitoring program, and a recording medium. [Background technology]
[0002] Anesthesia is generally used when performing surgery on a patient, but even if the patient is unconscious or numb due to anesthesia, muscle contraction may occur due to reflexes, etc. For this reason, during major surgery, muscle relaxants are administered to the patient to make the surgery easier by preventing the patient from moving. Before the start of surgery, preparations for surgery are made, such as administering an anesthetic, and a muscle relaxant is also administered at this time. After administering the muscle relaxant, the muscle relaxant state is monitored to check whether the patient has entered a muscle relaxant state. In addition, since the effect of the muscle relaxant decreases over time, the muscle relaxant state is monitored and the muscle relaxant is re-administered according to the progress of the surgery. As a device for monitoring the muscle relaxant state, a muscle relaxation monitoring device is used that stimulates the patient's nerves and measures the muscle contraction caused by the stimulation, as shown in Patent Documents 1 and 2. Patent Document 1 is a muscle relaxation monitoring device that measures the movement caused by muscle contraction caused by nerve stimulation in terms of acceleration.
[0003] On the other hand, Patent Document 2 shows an electromyography-type muscle relaxation monitoring device that electrically stimulates a nerve and measures the biosignals generated in the muscle as a response. In this muscle relaxation monitoring device, two stimulation electrodes are attached near the nerve, and two lead-out electrodes are attached near the muscle that contracts due to the nerve. The nerve is stimulated by passing a stimulation current from the stimulation output unit through the stimulation electrodes, and the biosignals generated in the muscle at this time are detected by the signal detection unit as electrical signals obtained through the lead-out electrodes.
[0004] In electromyography-based muscle relaxation monitoring devices, a stimulation current is applied, an electromyogram is obtained as a biological response, and the muscle relaxation state is monitored. The basic usage involves setting the current value of the stimulation current before administering a muscle relaxant, and then adjusting the current value of the stimulation current. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2006-326050 A [Patent Document 2] Patent Publication No. 2021-69724 Summary of the Invention [Problem to be solved by the invention]
[0006] In electromyography-based muscle relaxation monitoring devices, installation errors such as electrode peeling or incorrect attachment positioning may occur during the preparation for surgery or during surgery. There are various causes for installation errors in muscle relaxation monitoring devices, and when an error occurs, it is necessary to consider all possibilities and respond accordingly. Therefore, it may take time to prepare the muscle relaxation monitoring device or to recover from an installation error.
[0007] An object of one embodiment of the present invention is to enable identification of the cause of an abnormality in a muscle relaxation monitoring device during preparation for surgery, etc., so that the abnormality can be responded to quickly and preparation for surgery, etc. can be carried out quickly. [Means for solving the problem]
[0008] The muscle relaxation monitoring device in one embodiment of the present invention is characterized by comprising a stimulation output unit that stimulates nerves via stimulation electrodes attached to the subject's living body, a signal detection unit that detects biosignals generated from muscles in response to the stimulation of the nerves by the stimulation output unit as electrical signals via derived electrodes attached to the living body, and a cause determination unit that stimulates the nerves by the stimulation output unit and determines the cause of abnormal placement of the derived electrodes based on the electrical signals detected by the signal detection unit. Effect of the Invention
[0009] According to the present invention, by identifying the cause of an abnormality in the placement of the muscle relaxation monitoring device during preparation for surgery or during surgery, the abnormality can be dealt with promptly, so that preparation for surgery and surgery can be carried out promptly. [Brief description of the drawings]
[0010] [Figure 1] 1 is a diagram showing the configuration of a muscle relaxation monitoring system including a muscle relaxation monitoring device according to an embodiment; [Diagram 2] In an embodiment, an electromyogram of a living subject to no administration of a muscle relaxant. [Diagram 3] In an embodiment, an electromyogram obtained by the TOF method of a living body to which a muscle relaxant has not been administered. [Figure 4] In an embodiment, an electromyogram by the TOF method when a muscle relaxant is incompletely acting. [Diagram 5] 1 shows a first abnormal waveform in an embodiment. [Figure 6] 11 shows a second abnormal waveform in an embodiment. [Figure 7] 4 shows a third abnormal waveform in the embodiment. [Figure 8] 6 is a flow chart showing a procedure for determining and displaying the cause of an installation abnormality when setting the current value of the stimulation current in an embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] 1 shows the configuration of a muscle relaxation monitoring system in an embodiment attached to the upper limb L of a patient subject. The muscle relaxation monitoring system includes a muscle relaxation monitoring device 1, a display device 2, a speaker 3, a stimulating electrode 41, wiring 42, a derivation electrode 51, a signal line 52, a ground electrode 61, and a ground line 62. A pair of the stimulating electrode 41 and wiring 42 is provided, and a pair of the derivation electrode 51 and signal line 52 is also provided. The display device 2 and speaker 3 may be incorporated into the muscle relaxation monitoring device 1.
[0012] Muscle relaxation monitoring device 1 comprises a control unit 11, a memory unit 12, a stimulation output unit 13, a signal detection unit 14, a display output unit 15, an audio output unit 16, and an operation unit 17. The control unit 11 is composed of a CPU. The display output unit 15 and the audio output unit 16 are notification output units for notifying the results of muscle relaxation monitoring, but also function as notification output units for notifying abnormalities in the stimulation current, causes of installation abnormalities, and responses to be taken in response to the causes of the installation abnormalities.
[0013] The memory unit 12, the stimulation output unit 13, the signal detection unit 14, the display output unit 15, the audio output unit 16, and the operation unit 17 are connected to the control unit 11. The stimulation output unit 13 is connected to a pair of stimulation electrodes 41 via a pair of wirings 42, and the signal detection unit 14 is connected to a pair of derivation electrodes 51 via a pair of signal lines 52. The signal detection unit 14 is further connected to a ground electrode 61 via a ground wire 62. The stimulation electrode 41, the derivation electrode 51, and the ground electrode 61 are surface electrodes attached to the human body. The display output unit 15 of the muscle relaxation monitoring device 1 is connected to the display device 2, and the audio output unit 16 is connected to a speaker 3.
[0014] The upper limb L of the subject shown in FIG. 1 has an ulnar nerve extending inside the arm. The ulnar nerve is a nerve that contracts the adductor pollicis and abductor digiti minimi muscles in the hand. When using the muscle relaxation monitoring device 1, a stimulation electrode 41, a derived electrode 51, and a ground electrode 61 are attached to a living body. The pair of stimulation electrodes 41 are attached at positions corresponding to the ulnar nerve, and the pair of derived electrodes 51 are attached at positions corresponding to the abductor digiti minimi muscle and its nearby tendon. In addition, a ground electrode 61 is attached between the stimulation electrode 41 and the derived electrode 51.
[0015] The signal detection unit 14 detects the potential difference between two biosignals generated in the abductor digiti minimi muscle and tendon inputted through the signal line 52. The pair of stimulation electrodes 41 are attached along the ulnar nerve, and the stimulation output unit 13 applies a pulsed stimulation current through the wiring 42 and the stimulation electrode 41 to stimulate the ulnar nerve. In this embodiment, the period during which the stimulation current is applied is 0.2 msec. Then, the signal detection unit 14 detects the biosignal generated from the muscle reacting to the stimulation of the ulnar nerve as an electric signal between the pair of derived electrodes 51. The signal detection unit 14 has a differential amplifier and amplifies the potential difference between the pair of derived electrodes 51. Then, the signal detection unit 14 A / D converts the amplified voltage value and sends it to the control unit 11. The ground electrode 61 suppresses the influence of noise voltage transmitted from the subject's body to the upper limb L on the detected potential via the derived electrodes 51. The noise voltage is mainly generated by the voltage pulse due to the stimulation current and the propagation of the voltage pulse due to the stimulation current in the subject's body.
[0016] The derived data detected by the signal detection unit 14 and A / D converted is input to the control unit 11, where the muscle relaxation state is monitored. The monitoring results are displayed on the display device 2 via the display output unit 15, and are announced by voice from the speaker 3 via the audio output unit 16.
[0017] In addition, the muscle relaxation monitoring device 1 adjusts the stimulation current value by operating the switches on the operation unit 17. The control unit 11 and the memory unit 12 also function as a stimulation current value setting unit that adjusts the stimulation current and sets the stimulation current value in the preparation stage for surgery. Furthermore, the control unit 11 and the memory unit 12 also function as a cause determination unit that determines the cause of abnormal placement of the derivation electrodes 51, etc., based on the electrical signal detected by the signal detection unit 14.
[0018] As described above, in the muscle relaxation monitoring system, the muscle relaxation monitoring device 1 is connected to the upper limb L of the subject as shown in Fig. 1, and a stimulation current is applied from the stimulation output unit 13. Then, the biosignal generated in the muscle is detected as an electrical signal by the signal detection unit 14 to obtain an electromyogram. The stimulation current from the stimulation output unit 13 flows between the two stimulation electrodes 41 to stimulate the ulnar nerve, and the biosignal generated in the muscle connected to the ulnar nerve is detected by the signal detection unit 14 as an electrical signal of the voltage between the two lead-out electrodes 51. The biosignal changes depending on the muscle relaxation state caused by the action of a muscle relaxant.
[0019] FIG. 2 shows an example of an electromyogram of a living body to which a muscle relaxant has not been administered. The electromyogram shows the potential difference of the electric signal obtained from two deriving electrodes 51 attached to the upper limb L of the subject. The vertical axis shows the potential difference, and the horizontal axis shows the time. In order to prevent direct noise due to the stimulation current from appearing in the figure, the electromyogram in FIG. 2 shows the potential difference of the two deriving electrodes 51 immediately after the end of the 0.2 msec stimulation current pulse. The electromyogram in FIG. 2 shows a non-administration waveform E of a living body to which a muscle relaxant has not been administered.
[0020] The non-administration waveform E shown in Fig. 2 starts from a negative potential of the residual voltage due to the stimulation current, becomes a positive peak potential PPe of 6 mV at about 6 msec, becomes a negative peak potential NPe of -4 mV at about 11 msec, and then converges to a potential of 0 mV at about 20 msec. In Fig. 2, the biosignal period Tp, which is a period during which a biosignal is generated in the muscle by the stimulation current to the nerve, is 0 to about 20 msec. The non-administration waveform E has a shape generally as shown in Fig. 2, although the voltage value and timing of the peak potential vary slightly depending on the attachment state of the electrode and the characteristics of the living body.
[0021] On the other hand, when a muscle relaxant is administered, no biosignal is generated at the highest degree of muscle relaxation, the potential of the electrical signal is 0, and no positive peak potential PPe or negative peak potential NPe is generated. When the degree of muscle relaxation decreases, a biosignal is generated, but when multiple stimuli are applied in a short period of time, the biosignal for each application gradually decreases. By utilizing this, the muscle relaxation monitoring device 1 of the embodiment can monitor the degree of muscle relaxation by the TOF method (Train of Four). Note that the muscle relaxation monitoring device 1 can obtain electromyograms by various stimuli, not limited to the TOF method.
[0022] FIG. 3 shows an electromyogram representing a biosignal when stimulation is performed by the TOF method before administration of a muscle relaxant. In this embodiment, the TOF method is used to calculate the degree of muscle relaxation. In the TOF method of this embodiment, stimulation is performed by repeating one group every 15 seconds, with four consecutive stimuli at 500 msec intervals. The period of the stimulation current for stimulation is 0.2 msec. Stimulation is performed by passing a stimulation current from the stimulation output unit 13 between the stimulation electrodes 41 shown in FIG. 1. FIG. 3 shows four myoelectric potential waveforms W1 to W4 generated sequentially by four consecutive stimuli. The vertical axis indicates voltage value V, and the horizontal axis indicates time t.
[0023] In addition, the biosignal period Tp, which is the time width during which the potential of the myoelectric potential waveforms W1 to W4 fluctuates, is small compared to the 500 msec interval between stimuli. Therefore, for the sake of convenience, the timing of the stimuli is shortened for the myoelectric potential waveforms W1 to W4 in FIG. 3, and the starting points are shifted little by little in the positive direction of time t. The value of time t in FIG. 3 indicates the time of the myoelectric potential waveform W1 corresponding to the first stimulation. The starting point W1S of the myoelectric potential waveform W1 is 0 msec. The starting point W2S of the myoelectric potential waveform W2 is located at a time position of 500 msec in the t direction, but is drawn in the -t direction as shown in FIG. 3. The same is true for the myoelectric potential waveforms W3 and W4, with the starting points W3S and W4S at time positions of 1000 msec and 1500 msec, respectively. In addition, in order to avoid noise due to the stimulation current, the myoelectric potential waveforms W1 to W4 show the potential difference from immediately after the end of the stimulation current pulse, as in FIG. 2.
[0024] Before administration of a muscle relaxant, the myoelectric potential waveforms W1 to W4 have the shape of the non-administration waveform E shown in Figure 2, and the biosignal period Tp in the myoelectric potential waveforms W1 to W4 is also the same length. Figure 3 shows only the biosignal period Tp of the myoelectric potential waveform W1. As shown in Figure 3, the amplitudes f1 to f4, which are the difference between the maximum potential and the minimum potential in the biosignal period Tp, in the myoelectric potential waveforms W1 to W4, are the same. Before administration of a muscle relaxant, the amplitude of the myoelectric potential waveform does not decrease while one group of stimulation currents is applied.
[0025] In the TOF method, the ratio (TOF ratio) of the amplitude f1 of the myoelectric potential waveform W1 due to the first stimulus to the amplitude f4 of the myoelectric potential waveform W4 due to the fourth stimulus is expressed as a percentage and used as an index of muscle relaxation. The amplitudes f1 and f4 are the voltage values of the difference between the maximum and minimum potentials of the biosignal period Tp in the myoelectric potential waveforms W1 and W4, respectively. When the muscle relaxant is completely ineffective, the TOF ratio is 100%. In Figure 3, which shows the electromyogram before administration of the muscle relaxant, f1=f4, and the TOF ratio is 100%.
[0026] When the muscle relaxant is administered and the degree of muscle relaxation reaches its maximum, all of the myoelectric potential waveforms W1 to W4 become 0 mV (not shown). The amplitudes f1 to f4 also become 0 mV. In this state, even if the nerve is stimulated by a stimulation current, no biosignal is generated in the muscle, and the potential difference between the pair of leading electrodes 51 becomes 0 mV.
[0027] On the other hand, when the muscle relaxant has a weak effect, such as when time has passed since administration of a muscle relaxant, the amplitude f of the myoelectric potential waveform decreases with each increase in the number of stimuli in one group. Figure 4 shows an electromyogram representing a biosignal when stimulation is performed using the TOF method at this time. In Figure 4, one group is four consecutive stimuli at intervals of 500 msec, and stimulation is repeated for one group every 15 seconds. The period of the stimulation current for stimulation is 0.2 msec. Stimulation is performed by passing a stimulation current between the stimulation electrodes 41 shown in Figure 1.
[0028] FIG. 4 shows four myoelectric potential waveforms W1 to W4 that are generated sequentially by four consecutive stimuli. The vertical axis indicates the voltage value V, and the horizontal axis indicates the time t. The biosignal periods Tp in the myoelectric potential waveforms W1 to W4 are also the same length. FIG. 4 shows only the biosignal period Tp of the myoelectric potential waveform W1. Since the biosignal periods Tp of the myoelectric potential waveforms W1 to W4 are small compared to the 500 msec interval between stimuli, the timing of the stimuli is also shortened in FIG. 4 for the sake of convenience, and the starting points are shifted little by little in the positive direction of time t. The value of time t in FIG. 4 indicates the time of the myoelectric potential waveform W1 that corresponds to the first stimulation. Also, as in FIGS. 2 and 3, the myoelectric potential waveforms W1 to W4 indicate the potential difference from immediately after the pulse of the stimulation current ends. In FIG. 4, for the amplitudes f2 to f4 in the myoelectric potential waveforms W2 to W4, only amplitudes f1 and f4 are shown, and amplitudes f2 and f3 are omitted.
[0029] At a level of muscle relaxation where the effect of the muscle relaxant is weak, as shown in Fig. 4, the amplitude f1 of the myoelectric potential waveform W1 is the difference between the maximum and minimum potentials in the biosignal period Tp during which an electromyogram is generated. The biosignal period Tp shown in Fig. 4 is shown for the myoelectric potential waveform W1. Similarly, the amplitudes f2 to f4 in the myoelectric potential waveforms W2 to W4 indicate the difference between the maximum and minimum potentials during the period during which an electromyogram is generated. In the myoelectric potential waveforms W1 to W4 at a level of muscle relaxation where the effect of the muscle relaxant is weak, the amplitudes f1 to f4 are f1>f2>f3>f4, and gradually decrease.
[0030] In the muscle relaxation level where the effect of the muscle relaxant is weak as shown in FIG. 4, the TOF ratio = f4 / f1 is slightly less than 50%. Since it is considered that recovery from muscle relaxation is achieved when the TOF ratio is > 70%, the state of the electromyogram in FIG. 4 indicates that recovery from muscle relaxation is in progress and has not yet been achieved. Note that in FIG. 4, the myoelectric potential waveform W1 is the same as the non-administration waveform E, but the amplitude f1 of the myoelectric potential waveform W1 can be smaller than the amplitude fe of the non-administration waveform E. However, even if the amplitude f1 is reduced, the amplitude f4 is reduced by even more, so the TOF ratio can be used as an index of muscle relaxation.
[0031] The TOF ratio is monitored during surgery to determine whether or not to re-administer muscle relaxants. For example, if the TOF ratio is 40% or higher, a decision is made to re-administer muscle relaxants. In addition, during the preparation stage for surgery, the TOF ratio can be used to check whether the patient is in a muscle-relaxed state suitable for surgery. A TOF ratio of >70% is considered to indicate recovery from muscle relaxation, but in recent years, 80% or 90% is sometimes used as the standard.
[0032] <Use of the muscle relaxation monitoring device 1> Next, a usage form of the muscle relaxation monitoring device 1 in the embodiment will be described. First, in preparation for surgery, a pair of stimulation electrodes 41, a pair of lead-out electrodes 51, and a ground electrode 61 are attached to the upper limb L of a subject as shown in Fig. 1. Then, before administering a muscle relaxant, the current value of the stimulation current of the muscle relaxation monitoring device 1 is set.
[0033] When the stimulation current value setting switch is turned on using the operation unit 17, the muscle relaxation monitoring device 1 sets the current value of the stimulation current. In this embodiment, the cause of the installation abnormality is determined when the stimulation current value setting unit sets the current value of the stimulation current. When the stimulation current value is set, the current value of the stimulation current is gradually increased and automatically adjusted to an appropriate value. When an electromyogram is measured by the TOF method using the muscle relaxation monitoring device 1 after adjustment has been completed, the result is as shown in Figure 3, with a TOF ratio of 100%.
[0034] After the current value of the stimulation current has been set, a muscle relaxant is administered to the subject. The muscle relaxant gradually brings the subject into a state of muscle relaxation. In a completely relaxed state, the voltage of the electromyogram is 0 mV. After the muscle relaxant is administered, the amplitudes f1 to f4 of the myoelectric potential waveforms W1 to W4 in the TOF method during the process of reaching a completely relaxed state gradually decrease, as shown in Figure 4. The myoelectric potential waveforms W1 to W4 are electromyogram waveforms generated sequentially by the stimulation current at 500 msec intervals.
[0035] On the way to a complete muscle relaxation state, as shown in Figure 4, the amplitude of the myoelectric potential waveforms W1 to W4 becomes smaller as the number of consecutive stimulations increases due to the action of the muscle relaxant. In Figure 4, the TOF ratio is smaller than 70%, so it can be said that the muscle is in a muscle relaxation state. As the action of the muscle relaxant progresses further, the myoelectric potential waveforms W1 to W4 become approximately 0 mV, and the amplitudes f1 to f4 of the myoelectric potential waveforms W1 to W4 also become approximately 0 mV, resulting in a complete muscle relaxation state. After it is confirmed by the muscle relaxation monitoring device 1 that a sufficient muscle relaxation state has been achieved, surgery begins.
[0036] As time passes after administration of the muscle relaxant and its effect weakens, potential changes in the myoelectric potential waveforms W1 to W4 appear again, as shown in Figure 4. Then, when the TOF ratio exceeds a certain value, a decision is made as to whether or not to administer a muscle relaxant again, depending on factors such as the progress of the surgery.
[0037] As described above, in muscle relaxation monitoring device 1, a stimulation procedure and a detection procedure are performed by the TOF method. In the stimulation procedure, a nerve is stimulated by stimulation output unit 13 via stimulation electrode 41 attached to the living body. In the detection procedure, a biosignal generated from a muscle in response to the stimulation of the nerve by stimulation output unit 13 is detected as an electrical signal by signal detection unit 14 via lead-out electrode 51 attached to the living body. Control of the stimulation procedure and the detection procedure is executed by control unit 11 performing processing according to a program stored in memory unit 12.
[0038] <Determining the cause of installation abnormalities> When the stimulation current value setting switch is turned on in the preparation stage for surgery, muscle relaxation monitoring device 1 performs a stimulation procedure and a detection procedure, just as when monitoring muscle relaxation. In the stimulation procedure, the stimulation output unit 13 stimulates a nerve via stimulation electrode 41 attached to the living body. In the detection procedure, the signal detection unit 14 detects a biosignal generated from the muscle in response to the stimulation of the nerve by stimulation output unit 13 as an electrical signal via lead-out electrode 51 attached to the living body. The control of the stimulation procedure and detection procedure is executed by control unit 11 performing processing according to a program stored in memory unit 12.
[0039] During the preparation stage for surgery, if an electromyogram such as that shown in FIG. 2 is not obtained and an abnormal waveform is obtained as a result of performing the stimulation procedure and detection procedure to set the stimulation current, then it is possible that the cause is an abnormal installation of the muscle relaxation monitoring device 1. Similarly, if an abnormal waveform is obtained during surgery, it is possible that the cause is an abnormal installation of the muscle relaxation monitoring device 1. Abnormal waveforms can take a variety of shapes. The muscle relaxation monitoring device 1 stimulates a nerve using the stimulation output unit 13, and performs a determination procedure to determine the cause of the abnormal installation based on the electrical signal detected by the signal detection unit 14. The determination procedure is also controlled by the control unit 11 performing processing according to a program stored in the memory unit 12.
[0040] (1st abnormal waveform A1) In Fig. 5, the solid line shows the electrical signal of the first abnormal waveform A1 detected by the signal detection unit 14 after the nerve is stimulated by the stimulation output unit 13. The dotted line shows the non-administration waveform E of the electromyogram of a living body to which a muscle relaxant is not administered, as shown in Fig. 2. The first abnormal waveform A1 has a positive peak potential PPa1 and a negative peak potential NPa1 smaller than those of the non-administration waveform E during the biosignal period Tp. And, although there is an amplitude fa1, which is the difference between the maximum potential and the minimum potential during the period in which the electromyogram is generated, it is smaller than the amplitude fe of the non-administration waveform E.
[0041] An electromyogram like the first abnormal waveform A1 occurs when the nerve is not stimulated enough. Also, if the two derived electrodes 51 are too close to each other, it is difficult to capture the potential difference due to the biosignal, resulting in the first abnormal waveform A1. In this way, if the difference between the maximum potential and the minimum potential during the period when an electromyogram occurs after the nerve is stimulated by the stimulation output unit 13 is within a predetermined voltage range smaller than that of a normal electromyogram, the muscle relaxation monitoring device 1 judges that the waveform is the first abnormal waveform A1. The judgment that the waveform is the first abnormal waveform A1 means that there are two possible causes: insufficient nerve stimulation and abnormal proximity of the attachment positions of the two derived electrodes 51.
[0042] In the muscle relaxation monitoring device 1 of this embodiment, when the amplitude fa1, which is the difference between the positive peak potential PPa1 and the negative peak potential NPa1, is equal to or greater than the first reference value SV11 of 0.2 mV and equal to or less than the second reference value SV12 of 1.0 mV, the waveform is determined to be a first abnormal waveform A1. The range of the first reference value SV11 or more and the second reference value SV12 or less corresponds to a predetermined voltage range smaller than that of a normal electromyogram. The second reference value SV12 is set to a value smaller than the amplitude fe of the non-administration waveform E. The second reference value SV12 is preferably set to a value equal to or less than 1 / 2 the amplitude fe of the non-administration waveform E. In addition, the first reference value SV11 is set to a magnitude that allows the positive peak potential PPa1 and the negative peak potential NPa1 to be recognized.
[0043] During the current value setting of the stimulation current, the current value is gradually increased and the stimulation current is passed multiple times, but an upper limit is set for the stimulation current value. Then, it is determined whether the electromyogram for the stimulation current at the upper limit stimulation current value is the first abnormal waveform A1 or not. The determination that the first abnormal waveform A1 is the output of the signal detection unit 14 indicates that the cause of the abnormal placement is insufficient nerve stimulation, that the attachment positions of the two derived electrodes 51 are too close, or that the attachment positions are shifted from the tendon or muscle.
[0044] Then, the cause of the installation abnormality, which is the judgment result, is output from the display output unit 15 and displayed on the display device 2. The display device 2 displays "Insufficient nerve stimulation or abnormal approach to the attachment position of the derivation electrode." When displaying the message, an audio signal is output from the audio output unit 16, and a beep is made from the speaker 3 to alert the user.
[0045] In addition, the display upon determination may be a display notifying the user of the countermeasures according to the cause of the installation abnormality. In this case, for example, "Please attach the stimulation electrodes securely. If the abnormality is not resolved, please move the extraction electrodes away from the position and attach them again." is displayed.
[0046] In addition, if the first abnormal waveform A1 is obtained during muscle relaxation monitoring during surgery, the amplitude may be reduced due to the effect of a muscle relaxant. Therefore, even if the first abnormal waveform A1 is obtained, it is not determined that the cause is insufficient nerve stimulation, etc.
[0047] (2nd abnormal waveform A2) In Fig. 6, the solid line shows the electrical signal of the second abnormal waveform A2 detected by the signal detection unit 14 after the nerve is stimulated by the stimulation output unit 13. The dotted line shows the non-administration waveform E of the electromyogram of a living body to which a muscle relaxant has not been administered, as shown in Fig. 2. The second abnormal waveform A2 is a distorted waveform of the non-administration waveform E, and the absolute value of the initial voltage of the electromyogram is abnormally large. The electromyogram in Fig. 6 also shows the change in the electromyogram from the end of the stimulation current.
[0048] An electromyogram such as the second abnormal waveform A2 shown by the solid line in Fig. 6 is considered to be caused by the influence of the stimulation artifact noise remaining after the end point of the stimulation current generated by the stimulation current. The influence of the stimulation artifact noise on the electrical signal detected by the signal detection unit 14 is suppressed due to the presence of the ground electrode 61. However, if the ground electrode 61 is peeled off, the remaining stimulation artifact noise is not suppressed, resulting in an electromyogram such as the second abnormal waveform A2. Also, if the stimulation electrode 41 and the derivation electrode 51 are too close, the influence of the remaining stimulation artifact noise becomes large, resulting in the second abnormal waveform A2.
[0049] The stimulation artifact noise significantly affects the electrical signal detected by the signal detection unit 14 during a predetermined period after the end of the stimulation current. If the electrical signal is distorted during a predetermined period after the nerve is stimulated by the stimulation output unit 13, it is determined to be a second abnormal waveform A2. The determination that it is a second abnormal waveform A2 means that the cause of the installation abnormality is determined to be an abnormality in which the stimulation electrode 41 and the derivation electrode 51 are too close to each other, or an abnormality in which the ground electrode 61 is peeled off.
[0050] In the muscle relaxation monitoring device 1 of this embodiment, as shown in Fig. 6, when the absolute value of the average voltage in the first period Tp1, which is the initial period of the electromyogram, is 20 mV or more and the absolute value of the average voltage in the second period Tp2 is 10 mV or less, it is determined that the waveform is a second abnormal waveform A2. The first period Tp1 is 1 to 2 msec from the end of the stimulation current, and the second period Tp2 is 5 to 10 msec. In this way, by determining the absolute values of the average voltage in the first period Tp1 and the second period Tp2, it is possible to determine the distortion of the electrical signal in the biosignal period Tp, which is a predetermined period. The first period Tp1 and the second period Tp2 can be appropriately set during the manufacture of the muscle relaxation monitoring device 1 or before use.
[0051] During the current value setting of the stimulation current in preparation for surgery, the current value is gradually increased and the stimulation current is passed multiple times. In this case, it is determined whether the electromyogram for the stimulation current with the maximum current value is the second abnormal waveform A2.
[0052] When the output of the signal detection unit 14 is judged to be the second abnormal waveform A2, the control unit 11 judges that the installation abnormality is caused by the stimulation electrode 41 and the derivation electrode 51 being too close to each other, or by an abnormality in peeling off the ground electrode 61. The display output unit 15 then outputs the judgment result, which is the cause of the installation abnormality, and displays it on the display device 2. The display device 2 displays "The stimulation electrode and the derivation electrode are either too close to each other, or the ground electrode is peeled off." When displaying this, an audio signal is output from the audio output unit 16, and a beep is made from the speaker 3 to alert the user.
[0053] In addition, the display upon determination may be a display notifying the user of the countermeasures according to the cause of the installation abnormality. In this case, for example, the display may display "Please attach the ground electrode securely. If the abnormality is not resolved, please move the stimulating electrode and the derivation electrode away from each other."
[0054] (Third abnormal waveform A3) In Fig. 7, the solid line shows the electrical signal of the third abnormal waveform A3 detected by the signal detection unit 14 after the nerve is stimulated by the stimulation output unit 13. The dotted line shows the non-administration waveform E of the electromyogram of a living body to which a muscle relaxant has not been administered, as shown in Fig. 2. The first abnormal waveform A1 and the second abnormal waveform A2 show traces of the positive peak potential PPe and negative peak potential NPe due to the biological signal, but the third abnormal waveform A3 does not show these traces.
[0055] The third abnormal waveform A3 appears when the derivation electrode 51 is peeled off. When the derivation electrode 51 is peeled off, the waveform may be like the third abnormal waveform A3, but may also have a different shape. However, when the derivation electrode 51 is peeled off, it is difficult for any waveform to converge to a potential of 0 mV after the biosignal period Tp. The non-administration waveform E shown by the dotted line in FIG. 7 converges to a potential of 0 mV in the biosignal period Tp. On the other hand, the third abnormal waveform A3 shown by the solid line has a potential of about 5 mV 30 msec after the end of the stimulation current, which is after the biosignal period Tp.
[0056] As shown in Fig. 6, the second abnormal waveform A2 also converges slowly to a potential of 0 mV, as in the third abnormal waveform A3. Therefore, in the muscle relaxation monitoring device 1 of this embodiment, if the absolute value of the voltage at a judgment time point T, which is after the biosignal period Tp and 30 msec after the end of the stimulation current, is equal to or greater than a predetermined value of 2 mV, and if the waveform is not judged to be the second abnormal waveform A2, the waveform is judged to be the third abnormal waveform A3. The judgment time point T can be appropriately set during the manufacture of the muscle relaxation monitoring device 1 or before use. In this way, if the absolute value of the potential after the period in which the biosignal is generated after the stimulation of the nerve by the stimulation output unit 13 is equal to or greater than a predetermined value, the waveform is judged to be peeled off from the derivation electrode 51.
[0057] During the current value setting of the stimulation current in preparation for surgery, the current value is gradually increased and the stimulation current is passed multiple times. In this case, it is determined whether the electromyogram corresponding to the stimulation current with the maximum current value is the third abnormal waveform A3.
[0058] When the output of the signal detection unit 14 is judged to be the third abnormal waveform A3, the control unit 11 judges that the installation abnormality is caused by a peeling abnormality of the derivation electrode 51. Then, the display output unit 15 outputs the judgment result, which is the cause of the installation abnormality, and causes the display device 2 to display it. The display device 2 displays "A peeling abnormality has occurred in the derivation electrode." When displaying this, an audio signal is output from the audio output unit 16, and a beep is sounded from the speaker 3 to call attention.
[0059] Furthermore, the display displayed when the determination is made may be a display notifying the user of the countermeasures to be taken according to the cause of the installation abnormality. In this case, for example, a message such as "Please attach the lead-out electrodes securely" may be displayed.
[0060] <Flow of determining the cause of installation abnormalities> A flow for determining and displaying the cause of an installation abnormality is shown in Fig. 8. The steps in the flow diagram represent a method for monitoring muscle relaxation. This procedure is controlled by control unit 11 executing processing according to a muscle relaxation monitoring program stored in memory unit 12. This muscle relaxation monitoring program can be recorded on a computer-readable recording medium.
[0061] In this embodiment, the cause of the installation anomaly is determined when the stimulation current value setting unit sets the current value of the stimulation current. At the start, flags A1 to A4, which will be described later, are set to 0. When a stimulation current value setting switch (not shown) is turned on in the operation unit 17 shown in FIG. 1, a stimulation current value setting start signal is sent to the control unit 11. The control unit 11 sends a stimulation application signal to the stimulation output unit 13, and sets the current value of the stimulation current by repeating pulses of the stimulation current with gradually increasing current values (step S1).
[0062] As shown in Fig. 2, if an electromyogram with a positive peak potential PPe and a negative peak potential NPe is obtained within the expected voltage range during the expected biosignal period Tp, the current value of the stimulation current is successfully set. The success of the current value setting of the stimulation current is determined (step S2), and if the result is YES, the current value of the stimulation current at that time is stored, and the process proceeds to step S10 to display the completion of the current value setting of the stimulation current. The current value when the current value setting of the stimulation current is successful is stored as the current setting value and used as the current value of the stimulation current in the TOF method.
[0063] On the other hand, when the current value of the stimulation current is gradually increased and an electromyogram showing a positive peak potential PPe and a negative peak potential NPe within the expected voltage range during the expected biosignal period Tp as shown in Figure 2 is not obtained at the maximum current value, and step S2 is NO, the electromyogram for the stimulation current at the maximum current value is stored.
[0064] Then, it is determined whether the stored electromyogram is the first abnormal waveform A1 shown in FIG. 5 (step S3). When the amplitude fa1, which is the difference between the positive peak potential PPa1 and the negative peak potential NPa1 in the biosignal period Tp of the electromyogram, is equal to or greater than the first reference value SV11 of 0.2 mV and equal to or less than the second reference value SV12 of 1.0 mV, it is determined to be the first abnormal waveform A1. When it is determined to be the first abnormal waveform A1 of YES, the A1 flag is set to 1 (step S4). The A1 flag being 1 means that the nerve is not stimulated enough or the attachment position of the two derivation electrodes 51 is abnormal. When the difference between the maximum potential and the minimum potential during the period in which the biosignal is generated after the nerve is stimulated by the stimulation output unit 13 is within a predetermined voltage range smaller than that of a normal electromyogram, it is determined that the nerve is not stimulated enough or the attachment position of the two derivation electrodes 51 is abnormal. In this manner, it is determined that the nerve is not stimulated enough or the attachment position of the two derivation electrodes 51 is abnormal.
[0065] If it is determined in step S3 that the waveform is not the first abnormal waveform A1 (NO), it is determined whether the stored electromyogram is the second abnormal waveform A2 shown in FIG. 6 (step S5). If the absolute value of the average voltage in the first period Tp1 of 1 to 2 msec from the end of the stimulation current is 20 mV or more and the absolute value of the average voltage in the second period Tp2 of 5 to 10 msec is 10 mV or less, the electromyogram is determined to be the second abnormal waveform A2. If it is determined to be the second abnormal waveform A2 (YES), the A2 flag is set to 1 (step S6). The A2 flag being 1 means that the stimulation electrode 41 and the derivation electrode 51 are too close to each other, or that the ground electrode 61 is peeled off. In this manner, it is determined whether the stimulation electrode 41 and the derivation electrode 51 are too close to each other, or that the ground electrode 61 is peeled off.
[0066] If it is determined in step S5 that the waveform is not the second abnormal waveform A2 (NO), then it is determined whether the stored electromyogram is the third abnormal waveform A3 shown in Fig. 7 (step S7). If it is determined that the absolute value of the voltage of the electromyogram at the determination time point T 30 msec after the end of the stimulation current is 2 mV or more, then it is determined to be the third abnormal waveform A3. If it is determined to be the third abnormal waveform A3 (YES), then the A3 flag is set to 1 (step S6). The A3 flag being 1 indicates a peeling abnormality in the leading electrode 51.
[0067] In this flow, since step S7 for determining whether the waveform is the third abnormal waveform A3 is a determination made when it is determined that the waveform is not the second abnormal waveform A2, it is not necessary to determine that the waveform is not the second abnormal waveform A2 in step S7. In this manner, a determination is made as to whether the abnormality is that the stimulation electrode 41 and the derivation electrode 51 are too close to each other or that the ground electrode 61 is peeled off.
[0068] The A1 to A3 flags being 1 correspond to determining that the waveform is the first abnormal waveform A1 to the third abnormal waveform A3. Determination that the waveform is the first abnormal waveform A1 means that there is insufficient nerve stimulation or that the two derivation electrodes 51 are abnormally close to each other. Determination that the waveform is the second abnormal waveform A2 means that there is an abnormality in which the stimulation electrode 41 and the derivation electrode 51 are too close to each other or that the ground electrode 61 has peeled off. Determination that the waveform is the third abnormal waveform A3 means that there is an abnormality in which the derivation electrode 51 has peeled off. If it is determined in step S7 that the waveform is not the third abnormal waveform A3 (NO), the A4 flag is set to 1 (step S9). The A4 flag being 1 means that there is some other abnormality.
[0069] After steps S4, S6, S8, and S9, an attention calling sound is generated and the determination result is displayed according to the A1 to A4 flags (step S10). If any of the A1 to A4 flags is 1, the control unit 11 outputs a sound from the audio output unit 16 and generates a "beep" attention calling sound from the speaker 3. If all of the A1 to A4 flags are 0, a "beep" sound is generated. Furthermore, the control unit 11 outputs a display from the display output unit 15 and causes the display device 2 to display the determination result.
[0070] If any of the A1 to A4 flags are 1, the cause of the installation abnormality corresponding to the flag is displayed. If the A1 flag is 1, it displays "The nerve is not stimulated enough, or the attachment position of the derivation electrode is not close enough." If the A2 flag is 1, it displays "The stimulation electrode and derivation electrode are too close, or the ground electrode has come off." If the A3 flag is 1, it displays "The derivation electrode has come off." If the A4 flag is 1, it simply displays "Installation abnormality." If all of the A1 to A4 flags are 0, it displays "The stimulation current value setting has been completed."
[0071] When an installation abnormality is reported, the electrodes are reattached, and the stimulation current value setting switch is pressed again. Then, the stimulation current value is set again and the cause of the installation abnormality is determined and displayed according to the flow shown in Figure 8. This flow is repeated until the stimulation current value setting is successful and ends.
[0072] The above procedure is mainly for determining abnormalities when the current value of the stimulation current is set during preparation for surgery, but similar abnormality determination may also be performed when the muscle relaxation state is monitored using the TOF method after the current value of the stimulation current has been set. In that case, however, the determination is performed using an electromyogram for the current value of the stimulation current using the TOF method. However, when determining abnormalities during surgery, it is not determined whether the waveform is the first abnormal waveform A1 in step S3. This is because when a muscle relaxant is acting, a waveform similar to the first abnormal waveform A1 may result.
[0073] It should be noted that there is little need to judge whether or not the waveform is the first abnormal waveform A1 during surgery. Since the current value setting of the stimulation current has been completed, and the cause of the installation abnormality has already been judged once, it is unlikely that an abnormality in the approach of the attachment positions of the two derivation electrodes 51 will occur. It is also unlikely that the position of the stimulation electrode 41 will shift, resulting in insufficient stimulation of the nerve. If the stimulation electrode 41 becomes detached, this can be detected by monitoring the stimulation current.
[0074] The notification of the cause of the installation abnormality and the notification of the countermeasures may be both displayed, or only one of them may be displayed. The notification of the cause of the installation abnormality and the notification of the countermeasures may be made by voice from the speaker 3. The notification of the cause of the installation abnormality and the notification of the countermeasures by display device 2 and the notification of the countermeasures by voice from the speaker 3 may both be used, or only one of them may be used. In these cases, the display output unit 15 and the voice output unit 16 function as a notification output unit for notifying the cause of the installation abnormality and the countermeasures corresponding to the cause of the installation abnormality. The notification output unit may also be configured to light a light-emitting element or the like separately provided in the muscle relaxation monitoring device 1, or to vibrate a vibration device provided in the muscle relaxation monitoring device 1.
[0075] In the embodiment, the display device 2 and speaker 3 are separate devices in the muscle relaxation monitoring device 1. However, these may be integrated into one medical device. Also, the muscle relaxation monitoring device 1 may be incorporated into another medical device to form a medical device system, and information from the muscle relaxation monitoring device 1 may be notified using the display device, speaker, etc. of the other medical device.
[0076] In the embodiment, the use before administration of a muscle relaxant during preparation for surgery has been mainly described. However, it can also be used when any of the first to third abnormal waveforms A1 to A3 occurs during surgery, such as when the effect of the muscle relaxant weakens.
[0077] In this embodiment, the stimulating electrode 41 and the leading electrode 51 are connected to the muscle relaxation monitoring device 1 by the wiring 42 and the signal line. However, the stimulating electrode 41 may be connected to a stimulation device, and the stimulation device and the muscle relaxation monitoring device may be connected wirelessly. Alternatively, the leading electrode 51 may be connected to a signal detection device, and the signal detection device and the muscle relaxation monitoring device may be connected wirelessly. By connecting wirelessly, the amount of wiring required during surgery can be reduced.
[0078] In addition, the specific configuration is not limited to the embodiment, and the present invention includes design changes and the like that do not deviate from the gist of the present invention. In addition, the above-mentioned modified examples can be combined by utilizing each other's technology as long as there are no particular contradictions or problems in the purpose, configuration, etc. [Explanation of symbols]
[0079] L upper limb E Non-administration waveform Positive peak potential of waveform E without PPe administration Negative peak potential of waveform E without NPe administration fe Amplitude of non-administered waveform E W1-W4 Four myoelectric potential waveforms using the TOF method f1-f4 Amplitude of the four myoelectric potential waveforms in the TOF method A1 1st abnormal waveform A2 2nd abnormal waveform A3 3rd abnormal waveform PPa1 Positive peak potential of the first abnormal waveform A1 NPa1 Negative peak potential of the first abnormal waveform A1 fa1 Amplitude of the first abnormal waveform A1 Tp1 1st period Tp2 Second period Tp biosignal period T Judgment point 1. Muscle relaxation monitoring device 11 Control section 12 Storage section 13 Stimulation output unit 14 Signal detection section 15 Display output section 16 Audio output section 17 Control section 2 Display device 3 speakers 41 Stimulating electrode 42 Wiring 51 Lead-out electrode 52 Signal Line 61 Ground electrode 62 Ground wire
Claims
1. A stimulation output unit that stimulates nerves via a stimulation electrode attached to the living body of a subject; a signal detection unit that detects a biological signal generated from a muscle in response to a nerve stimulation by the stimulation output unit as an electrical signal via a lead electrode attached to the living body; a cause determination unit that stimulates a nerve by the stimulation output unit and determines a cause of an abnormality in placement of the derivation electrodes based on the electrical signal detected by the signal detection unit; A muscle relaxation monitoring device.
2. A notification output unit for notifying the cause of the installation abnormality is provided.
2. The muscle relaxation monitoring device according to claim 1.
3. A notification output unit is provided for notifying a response depending on the cause of the installation abnormality.
2. The muscle relaxation monitoring device according to claim 1.
4. A stimulation current value setting unit is provided for setting a current value of the stimulation current, When the stimulation current value setting unit sets the current value of the stimulation current, the cause of the installation abnormality is determined.
2. The muscle relaxation monitoring device according to claim 1.
5. When a difference between a maximum potential and a minimum potential during a period in which a biosignal is generated after the nerve is stimulated by the stimulation output unit is within a predetermined voltage range smaller than that of a normal electromyogram, it is determined that the nerve is not stimulated sufficiently or that the attachment positions of the two derivation electrodes are abnormally close to each other.
5. A muscle relaxation monitoring device according to claim 1.
6. When the electrical signal is distorted for a predetermined period after the nerve is stimulated by the stimulation output unit, the cause of the installation abnormality is determined to be an abnormality in which the stimulation electrode and the derivation electrode are too close to each other or an abnormality in which the ground electrode is peeled off.
5. A muscle relaxation monitoring device according to claim 1.
7. When an absolute value of a potential after a period in which a biological signal is generated is equal to or greater than a predetermined value after the nerve is stimulated by the stimulation output unit, the detection unit determines that an abnormality has occurred due to peeling of the leading electrode.
5. A muscle relaxation monitoring device according to claim 1.
8. On the computer, a stimulation step of stimulating a nerve via a stimulation electrode attached to a living body by a stimulation output unit; a detection step of detecting, by a signal detection unit, a biological signal generated from a muscle in response to a nerve stimulus by the stimulation output unit as an electrical signal via a leading electrode attached to the living body; and a muscle relaxation monitoring program for executing the detection step, a determination step of stimulating a nerve by the stimulation output unit and determining a cause of an installation abnormality based on the electrical signal detected by the signal detection unit; A muscle relaxation monitoring program to carry out the following:
9. On the computer, a stimulation step of stimulating a nerve via a stimulation electrode attached to a living body by a stimulation output unit; a detection step of detecting, by a signal detection unit, a biological signal generated from a muscle in response to a nerve stimulus by the stimulation output unit as an electrical signal via a leading electrode attached to the living body; and a muscle relaxation monitoring program for executing the detection step, a determination step of stimulating a nerve by the stimulation output unit and determining a cause of an installation abnormality based on the electrical signal detected by the signal detection unit; A computer-readable recording medium having recorded thereon a muscle relaxation monitoring program for executing the above.
Citation Information
Patent Citations
Anesthesia monitoring system and method for monitoring anesthesia
JP2015506245A
Detection of Skin Electrode Abrasion Using Electrode-Skin Impedance
JP2016515428A
Information transmission device
JP2020065852A
Negative undershoot prevention device for semiconductor memory
KR2020000002073U
Method of displaying muscle relaxation parameters and monitor for displaying muscle relaxation state
JP2006326050A
Cited By
Muscle relaxation monitoring device and medical device system
EP4806500A1
Muscle relaxation monitoring device and medical device system
JP2026152431A
